Doximity, Inc. $DOCS Stake Boosted by Raymond James Financial Inc.

Raymond James Financial Inc. increased its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 11.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 194,809 shares of the company’s stock after purchasing an additional 20,717 shares during the quarter. Raymond James Financial Inc. owned 0.10% of Doximity worth $11,305,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC bought a new position in Doximity during the first quarter worth $29,000. Allworth Financial LP lifted its stake in Doximity by 104.0% during the first quarter. Allworth Financial LP now owns 563 shares of the company’s stock worth $32,000 after purchasing an additional 287 shares during the last quarter. National Bank of Canada FI bought a new position in Doximity during the first quarter worth $33,000. Spire Wealth Management lifted its stake in Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after purchasing an additional 260 shares during the last quarter. Finally, Cullen Frost Bankers Inc. bought a new position in Doximity during the first quarter worth $64,000. 87.19% of the stock is currently owned by institutional investors.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the sale, the director directly owned 6,360 shares in the company, valued at $381,600. The trade was a 61.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $63.00, for a total transaction of $315,000.00. Following the sale, the director owned 16,618 shares in the company, valued at approximately $1,046,934. This represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 36,000 shares of company stock worth $2,140,940 over the last ninety days. 31.30% of the stock is currently owned by corporate insiders.

Doximity Stock Down 0.7%

Shares of NASDAQ DOCS opened at $67.94 on Friday. Doximity, Inc. has a fifty-two week low of $35.32 and a fifty-two week high of $85.21. The firm’s 50-day simple moving average is $61.83 and its 200 day simple moving average is $60.25. The stock has a market cap of $12.72 billion, a P/E ratio of 67.94, a P/E/G ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the company earned $0.28 EPS. The company’s revenue for the quarter was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, sell-side analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on DOCS shares. BTIG Research upgraded Doximity from a “neutral” rating to a “buy” rating and set a $80.00 price objective on the stock in a research note on Monday, June 2nd. Canaccord Genuity Group raised their target price on Doximity from $50.00 to $59.00 and gave the company a “hold” rating in a research note on Friday, August 8th. Evercore ISI upgraded Doximity from an “in-line” rating to an “outperform” rating and raised their target price for the company from $50.00 to $70.00 in a research note on Wednesday, July 9th. Robert W. Baird cut their target price on Doximity from $87.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Finally, Truist Financial raised their target price on Doximity from $52.00 to $61.00 and gave the company a “hold” rating in a research note on Thursday, July 17th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $66.21.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.